INCYTE CORPORATION Payments to Acquire Productive Assets
INCYTE CORPORATION (INCY) reported Payments to Acquire Productive Assets of $77.83 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2023-02-07
- INCYTE CORPORATION payments to acquire productive assets for the quarter ending 2022-12-31 was $21.27M, a 38.27% decline year-over-year.
- INCYTE CORPORATION payments to acquire productive assets for the quarter ending 2022-09-30 was $27.81M, a 13.50% decline year-over-year.
- INCYTE CORPORATION payments to acquire productive assets for the quarter ending 2022-06-30 was $11.74M, a 82.29% decline year-over-year.
- INCYTE CORPORATION payments to acquire productive assets for the quarter ending 2022-03-31 was $17.01M, a 64.63% decline year-over-year.
- INCYTE CORPORATION payments to acquire productive assets for fiscal 2022 was $77.83M, a 57.00% decline from fiscal 2021.
- INCYTE CORPORATION payments to acquire productive assets for fiscal 2021 was $181.01M, a 3.40% decline from fiscal 2020.
- INCYTE CORPORATION payments to acquire productive assets for fiscal 2020 was $187.38M, a 140.03% increase from fiscal 2019.
- INCYTE CORPORATION payments to acquire productive assets for fiscal 2019 was $78.06M, a 6.23% increase from fiscal 2018.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | $21.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $49.08M derived: sum of 2 quarters · filed 2023-02-07 | $60.83M derived: sum of 3 quarters · filed 2023-02-07 | $77.83M 10-K · filed 2023-02-07 |
| 2022-09-30 | $27.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $39.55M derived: sum of 2 quarters · filed 2022-11-01 | $56.56M 10-Q · filed 2022-11-01 | $91.02M derived: sum of 4 quarters · filed 2023-02-07 |
| 2022-06-30 | $11.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $28.75M 10-Q · filed 2022-08-02 | $63.21M derived: sum of 3 quarters · filed 2023-02-07 | $95.36M derived: sum of 4 quarters · filed 2023-02-07 |
| 2022-03-31 | $17.01M 10-Q · filed 2022-05-03 | $51.47M derived: sum of 2 quarters · filed 2023-02-07 | $83.62M derived: sum of 3 quarters · filed 2023-02-07 | $149.93M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-12-31 | $34.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $66.62M derived: sum of 2 quarters · filed 2023-02-07 | $132.92M derived: sum of 3 quarters · filed 2023-02-07 | $181.01M 10-K · filed 2023-02-07 |
| 2021-09-30 | $32.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $98.46M derived: sum of 2 quarters · filed 2022-11-01 | $146.54M 10-Q · filed 2022-11-01 | $197.98M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $66.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $114.39M 10-Q · filed 2022-08-02 | $165.82M derived: sum of 3 quarters · filed 2023-02-07 | $218.64M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $48.08M 10-Q · filed 2022-05-03 | $99.52M derived: sum of 2 quarters · filed 2023-02-07 | $152.34M derived: sum of 3 quarters · filed 2023-02-07 | $196.20M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $51.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $104.25M derived: sum of 2 quarters · filed 2023-02-07 | $148.11M derived: sum of 3 quarters · filed 2023-02-07 | $187.38M 10-K · filed 2023-02-07 |
| 2020-09-30 | $52.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $96.68M derived: sum of 2 quarters · filed 2021-11-02 | $135.95M 10-Q · filed 2021-11-02 | $165.26M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $43.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $83.13M 10-Q · filed 2021-08-03 | $112.44M derived: sum of 3 quarters · filed 2022-02-08 | $95.63M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $39.27M 10-Q · filed 2021-05-04 | $68.58M derived: sum of 2 quarters · filed 2022-02-08 | $51.77M derived: sum of 3 quarters · filed 2022-02-08 | $99.06M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $29.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $12.50M derived: sum of 2 quarters · filed 2022-02-08 | $59.80M derived: sum of 3 quarters · filed 2022-02-08 | $78.06M 10-K · filed 2022-02-08 |
| 2019-09-30 | -$16.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $30.48M derived: sum of 2 quarters · filed 2020-11-05 | $48.75M 10-Q · filed 2020-11-05 | $74.03M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $47.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $65.56M 10-Q · filed 2020-08-04 | $90.84M derived: sum of 3 quarters · filed 2021-02-09 | $115.66M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $18.27M 10-Q · filed 2020-05-05 | $43.55M derived: sum of 2 quarters · filed 2021-02-09 | $68.37M derived: sum of 3 quarters · filed 2021-02-09 | $79.16M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $25.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $50.10M derived: sum of 2 quarters · filed 2021-02-09 | $60.89M derived: sum of 3 quarters · filed 2021-02-09 | $73.48M 10-K · filed 2021-02-09 |
| 2018-09-30 | $24.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $35.61M derived: sum of 2 quarters · filed 2019-10-29 | $48.20M 10-Q · filed 2019-10-29 | $73.45M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $10.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $23.38M 10-Q · filed 2019-07-30 | $48.63M derived: sum of 3 quarters · filed 2020-02-13 | $82.94M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $12.59M 10-Q · filed 2019-04-30 | $37.84M derived: sum of 2 quarters · filed 2020-02-13 | $72.14M derived: sum of 3 quarters · filed 2020-02-13 | $102.64M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $25.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $59.55M derived: sum of 2 quarters · filed 2020-02-13 | $90.05M derived: sum of 3 quarters · filed 2020-02-13 | $111.02M 10-K · filed 2020-02-13 |
| 2017-09-30 | $34.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $64.80M derived: sum of 2 quarters · filed 2018-10-30 | $85.77M 10-Q · filed 2018-10-30 | $101.64M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $30.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $51.47M 10-Q · filed 2018-07-31 | $67.34M derived: sum of 3 quarters · filed 2019-02-14 | $83.97M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $20.97M 10-Q · filed 2018-05-01 | $36.84M derived: sum of 2 quarters · filed 2019-02-14 | $53.47M derived: sum of 3 quarters · filed 2019-02-14 | $135.68M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $15.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $32.50M derived: sum of 2 quarters · filed 2019-02-14 | $114.72M derived: sum of 3 quarters · filed 2019-02-14 | $120.28M 10-K · filed 2019-02-14 |
| 2016-09-30 | $16.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $98.84M derived: sum of 2 quarters · filed 2017-10-31 | $104.41M 10-Q · filed 2017-10-31 | $111.30M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $82.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $87.78M 10-Q · filed 2017-08-01 | $94.67M derived: sum of 3 quarters · filed 2018-02-15 | $108.03M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $5.56M 10-Q · filed 2017-05-04 | $12.46M derived: sum of 2 quarters · filed 2018-02-15 | $25.82M derived: sum of 3 quarters · filed 2018-02-15 | $28.01M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $20.25M derived: sum of 2 quarters · filed 2018-02-15 | $22.45M derived: sum of 3 quarters · filed 2018-02-15 | $26.00M 10-K · filed 2018-02-15 |
| 2015-09-30 | $13.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $15.55M derived: sum of 2 quarters · filed 2016-11-01 | $19.11M 10-Q · filed 2016-11-01 | $24.96M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $5.75M 10-Q · filed 2016-08-09 | $11.60M derived: sum of 3 quarters · filed 2017-02-14 | $22.26M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $3.55M 10-Q · filed 2016-05-09 | $9.41M derived: sum of 2 quarters · filed 2017-02-14 | $20.07M derived: sum of 3 quarters · filed 2017-02-14 | $28.77M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $5.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $16.51M derived: sum of 2 quarters · filed 2017-02-14 | $25.21M derived: sum of 3 quarters · filed 2017-02-14 | $27.88M 10-K · filed 2017-02-14 |
| 2014-09-30 | $10.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $19.36M derived: sum of 2 quarters · filed 2015-11-03 | $22.02M 10-Q · filed 2015-11-03 | $24.05M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $11.36M 10-Q · filed 2015-08-04 | $13.39M derived: sum of 3 quarters · filed 2016-02-12 | $14.18M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $2.66M 10-Q · filed 2015-04-30 | $4.69M derived: sum of 2 quarters · filed 2016-02-12 | $5.48M derived: sum of 3 quarters · filed 2016-02-12 | $6.04M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $2.82M derived: sum of 2 quarters · filed 2016-02-12 | $3.37M derived: sum of 3 quarters · filed 2016-02-12 | $4.27M 10-K · filed 2016-02-12 |
| 2013-09-30 | $789.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $1.34M derived: sum of 2 quarters · filed 2014-10-30 | $2.24M 10-Q · filed 2014-10-30 | $3.17M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $553.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $1.45M 10-Q · filed 2014-07-31 | $2.38M derived: sum of 3 quarters · filed 2015-02-17 | $2.78M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $894.00K 10-Q · filed 2014-05-01 | $1.82M derived: sum of 2 quarters · filed 2015-02-17 | $2.23M derived: sum of 3 quarters · filed 2015-02-17 | $3.24M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $1.34M derived: sum of 2 quarters · filed 2015-02-17 | $2.34M derived: sum of 3 quarters · filed 2015-02-17 | $2.84M 10-K · filed 2015-02-17 |
| 2012-09-30 | $406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.41M derived: sum of 2 quarters · filed 2013-10-31 | $1.91M 10-Q · filed 2013-10-31 | $2.90M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $1.50M 10-Q · filed 2013-08-01 | $2.50M derived: sum of 3 quarters · filed 2014-02-21 | $3.67M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $496.00K 10-Q · filed 2013-05-02 | $1.49M derived: sum of 2 quarters · filed 2014-02-21 | $2.67M derived: sum of 3 quarters · filed 2014-02-21 | $3.74M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $992.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $2.17M derived: sum of 2 quarters · filed 2014-02-21 | $3.25M derived: sum of 3 quarters · filed 2014-02-21 | $3.80M 10-K · filed 2014-02-21 |
| 2011-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $2.25M derived: sum of 2 quarters · filed 2012-11-01 | $2.81M 10-Q · filed 2012-11-01 | $5.55M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $1.63M 10-Q · filed 2012-08-03 | $4.37M derived: sum of 3 quarters · filed 2013-02-21 | $4.83M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $552.00K 10-Q · filed 2012-04-26 | $3.29M derived: sum of 2 quarters · filed 2013-02-21 | $3.76M derived: sum of 3 quarters · filed 2013-02-21 | $4.36M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $3.21M derived: sum of 2 quarters · filed 2013-02-21 | $3.80M derived: sum of 3 quarters · filed 2013-02-21 | $4.11M 10-K · filed 2013-02-21 |
| 2010-09-30 | $466.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $1.06M derived: sum of 2 quarters · filed 2011-10-27 | $1.37M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $598.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $904.00K 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $306.00K 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $387.00K 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |